Urogenital carcinoma tlp complex peptides and antibodies...

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 14/705 (2006.01) A61K 38/08 (2006.01) A61K 39/00 (2006.01) C07K 7/06 (2006.01) C07K 14/47 (2006.01) C07K 16/30 (2006.01) G01N 33/574 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2234151

It is described a peptide comprising a specific urogenital carcinoma TLP epitope, wherein the TLP comprises the aminoacid sequence: GlyProProGluValGlnAsnAlaAsn. Also described are reagents to detect said urogenital TLPs and pharmaceutical compositions.

Peptide qui comprend un épitope spécifique de TLP (protéines libérées par des tumeurs) de carcinome urogénital, les TLP comportant la séquence d'acides aminés GlyProProGluValGlnAsnAlaAsn. Des réactifs permettant de détecter ces TLP urogénitales et des compositions pharmaceutiques sont également décrites.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Urogenital carcinoma tlp complex peptides and antibodies... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Urogenital carcinoma tlp complex peptides and antibodies..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Urogenital carcinoma tlp complex peptides and antibodies... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1917575

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.